EyePoint Pharmaceuticals, Inc.

Q2 2024 13F Holders

Symbol
EYPT
CUSIP
30233G209
Type
Equity
Class
COM NEW
Num filings
165
Total reported value, excl. options
$530 M
Manager Report Date Value ($000) Shares Option Type